These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3017754

  • 1. LLC-PK1 cell mutants in cAMP metabolism respond normally to phorbol esters.
    Jans DA, Hemmings BA.
    FEBS Lett; 1986 Sep 01; 205(1):127-31. PubMed ID: 3017754
    [Abstract] [Full Text] [Related]

  • 2. Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells.
    Jans DA, Resink TJ, Hemmings BA.
    Biochem J; 1987 Apr 15; 243(2):413-8. PubMed ID: 2820380
    [Abstract] [Full Text] [Related]

  • 3. Pathway of urokinase-type plasminogen activator induction in the T47D and LLC-PK1 cell lines.
    Jans DA, Dierks-Ventling C, Hemmings BA.
    Exp Cell Res; 1987 Sep 15; 172(1):76-83. PubMed ID: 3653259
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of cAMP-mediated gene induction: examination of renal epithelial cell mutants affected in the catalytic subunit of the cAMP-dependent protein kinase.
    Pearson D, Nigg EA, Nagamine Y, Jans DA, Hemmings BA.
    Exp Cell Res; 1991 Jan 15; 192(1):315-8. PubMed ID: 1898592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of two mutants of the LLC-PK1 porcine kidney cell line affected in the catalytic subunit of the cAMP-dependent protein kinase.
    Botterell SH, Jans DA, Hemmings BA.
    Eur J Biochem; 1987 Apr 01; 164(1):39-44. PubMed ID: 2435550
    [Abstract] [Full Text] [Related]

  • 8. Induction and desensitization of plasminogen activator gene expression by tumor promoters.
    Degen JL, Estensen RD, Nagamine Y, Reich E.
    J Biol Chem; 1985 Oct 15; 260(23):12426-33. PubMed ID: 3862668
    [Abstract] [Full Text] [Related]

  • 9. Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function.
    Jans DA, Resink TJ, Wilson LE, Reich E, Hemmings BA.
    Eur J Biochem; 1986 Oct 15; 160(2):407-12. PubMed ID: 3021458
    [Abstract] [Full Text] [Related]

  • 10. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition.
    Nagamine Y, Ziegler A.
    EMBO J; 1991 Jan 15; 10(1):117-22. PubMed ID: 1846595
    [Abstract] [Full Text] [Related]

  • 11. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
    Botteri FM, Ballmer-Hofer K, Rajput B, Nagamine Y.
    J Biol Chem; 1990 Aug 05; 265(22):13327-34. PubMed ID: 1695907
    [Abstract] [Full Text] [Related]

  • 12. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
    Hofstetter P, Kikinis Z, Altus MS, Pearson D, Nagamine Y.
    Mol Cell Biol; 1987 Dec 05; 7(12):4535-41. PubMed ID: 2830499
    [Abstract] [Full Text] [Related]

  • 13. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
    Jans DA, Resink TJ, Hemmings BA.
    Arch Biochem Biophys; 1991 Mar 05; 285(2):377-81. PubMed ID: 1716864
    [Abstract] [Full Text] [Related]

  • 14. Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor.
    Jans DA, Pavo I, Fahrenholz F.
    FEBS Lett; 1993 Jan 04; 315(2):134-8. PubMed ID: 8380270
    [Abstract] [Full Text] [Related]

  • 15. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
    Ziegler A, Hagmann J, Kiefer B, Nagamine Y.
    J Biol Chem; 1990 Dec 05; 265(34):21194-201. PubMed ID: 1701176
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
    Ziegler A, Knesel J, Fabbro D, Nagamine Y.
    J Biol Chem; 1991 Nov 05; 266(31):21067-74. PubMed ID: 1718970
    [Abstract] [Full Text] [Related]

  • 17. A system to select for mutant LLC-PK1 cells affected in cAMP mediated hormonal response using a photoactivatable analogue of vasopressin.
    Luzius H, Jans DA, Fahrenholz F.
    J Recept Res; 1990 Nov 05; 10(1-2):61-80. PubMed ID: 2175811
    [Abstract] [Full Text] [Related]

  • 18. Complementation between LLC-PK1 mutants affected in polypeptide hormone-receptor function.
    Jans DA, Resink TJ, Hemmings BA.
    Eur J Biochem; 1987 Feb 02; 162(3):571-6. PubMed ID: 3030741
    [Abstract] [Full Text] [Related]

  • 19. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP.
    Andrus L, Altus MS, Pearson D, Grattan M, Nagamine Y.
    J Biol Chem; 1988 May 05; 263(13):6183-7. PubMed ID: 3360780
    [Abstract] [Full Text] [Related]

  • 20. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
    Marksitzer R, Stief A, Menoud PA, Nagamine Y.
    J Biol Chem; 1995 Sep 15; 270(37):21833-8. PubMed ID: 7665606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.